Evidence map›Paper›PMID 40220915›Full record

ArticleNeurobiology of disease2025

Conservation of strain properties of bank vole-adapted chronic wasting disease in the absence of glycosylation and membrane anchoring.

Enric Vidal, Hasier Eraña, Jorge M Charco, Nuria L Lorenzo, Samanta Giler, Montserrat Ordóñez, Eva Fernández-Muñoz, Maitena San-Juan-Ansoleaga, Glenn C Telling, Manuel A Sánchez-Martín and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurobiology of disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Enric VidalIRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia. Spain; Unitat mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia. Spain. Electronic address: enric.vidal@irta.cat.
Hasier ErañaCenter for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades infecciosas (CIBERINFEC), Carlos III National Health Institute, Madrid, Spain; ATLAS Molecular Pharma S. L., Derio, Spain. Electronic address: herana.atlas@cicbiogune.es.
Jorge M CharcoCenter for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades infecciosas (CIBERINFEC), Carlos III National Health Institute, Madrid, Spain; ATLAS Molecular Pharma S. L., Derio, Spain. Electronic address: jmoreno@cicbiogune.es.
Nuria L LorenzoCIMUS Biomedical Research Institute, University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain; Department of Medical Sciences, University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain. Electronic address: nuria.lopez.lorenzo2@usc.es.
Samanta GilerIRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia. Spain; Unitat mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia. Spain. Electronic address: samanta.giler@irta.cat.
Montserrat OrdóñezIRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia. Spain; Unitat mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia. Spain. Electronic address: montserrat.ordonez@irta.cat.
Eva Fernández-MuñozCenter for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain. Electronic address: efernandez@cicbiogune.es.
Maitena San-Juan-AnsoleagaCenter for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain. Electronic address: msanjuan.visitor@cicbiogune.es.
Glenn C TellingPrion Research Center, Colorado State University, Fort Collins, USA. Electronic address: glenn.Telling@colostate.edu.
Manuel A Sánchez-MartínTransgenic Facility, Department of Medicine, University of Salamanca, Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. Electronic address: adolsan@usal.es.
Mariví GeijoAnimal Health Department, NEIKER-Basque Institute for Agricultural Research and Development, Basque Research and Technology Alliance (BRTA), Derio, Spain. Electronic address: mgeijo@neiker.eus.
Jesús R RequenaCIMUS Biomedical Research Institute, University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain; Department of Medical Sciences, University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain. Electronic address: jesus.requena@usc.es.
Joaquín CastillaCenter for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain; Centro de Investigación Biomédica en Red de Enfermedades infecciosas (CIBERINFEC), Carlos III National Health Institute, Madrid, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain. Electronic address: castilla@joaquincastilla.com.

Funding

Zoonotic potential of CWD and influence of environmental contamination on prion propagationP01AI077774 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CLAUDIO SOTO · 2008 to 2026
$36.1M
NIAID NIH HHS P01 AI077774
6 · The paper itself

Abstract

Prion disease phenotypes (prion strains) are primarily determined by the specific misfolded conformation of the cellular prion protein (PrP

Indexed as

PrPC ProteinsWasting Disease, ChronicAnimalsArvicolinaeBrainGlycosylationGlycosylphosphatidylinositolsMiceMice, TransgenicGlycosylphosphatidylinositolsPrPC ProteinsChronic wasting diseaseGlycosylationPrionPrion strainsTransmissible spongiform encephalopathies

Identifiers

PMID40220915
PMCPMC12900078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.